Clinical trial Recruiting at 1 site Interventional Ages 4 to 15

Exploring the gut-brain connection in autism with probiotics and AI

Official title: Precision Health in Autism: Exploring the Gut-Brain-Behavior Axis With Biomarkers, Probiotic Efficacy, and Artificial Intelligence Algorithms

Run by National Taiwan University Hospital · NCT06677840 · Data updated 2026-11-12

This study is testing if a specific probiotic can help improve symptoms of autism while also looking at how behavioral therapies and new technology can better support people with autism.

Quick facts

Study typeInterventional
Ages4 Years to 15 Years
SexAll
Enrollment110 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedMay 1, 2024
Main results expectedApril 30, 2027
Study endsApril 30, 2028
Registry record updatedJuly 9, 2026
Trial IDNCT06677840 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 4 to 15 who have a clinical diagnosis of ASD.

Probably not a fit

Patients with major psychiatric or neurological disorders, or those who have recently consumed antibiotics or probiotics, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This innovative study investigates the relationship between gut microbiota and autism spectrum disorder (ASD) through a randomized, double-blind, placebo-controlled trial using the probiotic Clostridium butyricum GKB7. It aims to assess the treatment effects of probiotics on ASD symptoms while also exploring the efficacy of behavioral interventions like Naturalistic Developmental Behavioral Interventions and PEERS®. Additionally, the study will develop an artificial intelligence platform to integrate various data types for improved diagnosis and treatment of ASD. The findings are expected to enhance understanding of ASD and contribute to precision medicine approaches.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for children with autism spectrum disorder.

How similar studies have gone: While there have been studies exploring the gut-brain axis in ASD, this approach combining probiotics and AI for diagnosis and treatment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children and adolescents aged 4 to 15 who are clinically diagnosed with ASD according to DSM-5 criteria and confirmed by the ADI-R/ADOS.
* Caregivers cooperate with all the assessments and stool and blood collection.

Exclusion Criteria:

* A history of major psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depression), neurological disorders, and substances use disorders.
* Difficulty following instructions.
* Consumption of antibiotics and yogurt or probiotic products two weeks prior to enrollment.

Where it's running

  • National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.